Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Prostate Cancer treatment details. Chemotherapy. Leon Berard , Lyon, France



Survival: 11.4 months
   
Toxicity Grade: 4
   
Treatments: Chemotherapy
   
Drugs: Adrucil
Eloxatin
Country: France
   
City/State/Province: Lyon
   
Hospital: Leon Berard
   
Journal: Link
   
Date: 8/2003

Description:
Patients: This Phase II randomized study involved 54 patients with hormone refractory metastatic prostate cancer. Patients were divided into two groups: Group 1 with 26 patients and Group 2 with 28 patients. For patients in Group 1, the median age was 68 and the median PSA was 85. For patients in Group 2, the median age was 68 and the median PSA was 254.

Treatment: For patients in Group 2, the treatment consisted of the chemotherapy drugs oxaliplatin (eloxatin) and 5-fluorouracil (5-FU).

Toxicity: For patients in Group 2, grade 3-4 toxicities included anemia, neutropenia, thrombocytopenia, vomiting, stomatitis, asthenia, and neurosensory.

Results: For patients in Group 2 the median overall survival was 11.4 months.

Support: The study was supported by a grant from Sanofi-Synthelabo. This company manufactures oxaliplatin (eloxatin).

Correspondence: Dr. S. Mackenzie

E-mail to a Friend Email Physician More Information